Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-09-10 16:33:02 ET · period of report 2026-09-08 · accession 0001607737-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-10 16:33 | 2026-09-08 | JAZZ | GALA RENEE D | Pres, CEO | F - Tax | $246.81 | -1,967 | 145.4K | -1% | -$485.5K |
| T | 2026-09-10 16:33 | 2026-09-08 | JAZZ | GALA RENEE D | Pres, CEO | S - Sale | $243.03 | -2,000 | 143.4K | -1% | -$486.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-08 | F | D | 1,967 | $246.81 | 145,394 | D | — | — | (F1) Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. |
| 2 | Common | Ordinary Shares | 2026-09-08 | S | D | 2,000 | $243.03 | 143,394 | D | — | — | (F2) This transaction was made pursuant to a plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |